Literature DB >> 29572594

Blood pool and tissue phase patient motion effects on 82rubidium PET myocardial blood flow quantification.

Edward P Ficaro1,2, Venkatesh L Murthy2, Benjamin C Lee3, Jonathan B Moody1, Alexis Poitrasson-Rivière1, Amanda C Melvin2, Richard L Weinberg4, James R Corbett1,2.   

Abstract

BACKGROUND: Patient motion can lead to misalignment of left ventricular volumes of interest and subsequently inaccurate quantification of myocardial blood flow (MBF) and flow reserve (MFR) from dynamic PET myocardial perfusion images. We aimed to identify the prevalence of patient motion in both blood and tissue phases and analyze the effects of this motion on MBF and MFR estimates.
METHODS: We selected 225 consecutive patients that underwent dynamic stress/rest rubidium-82 chloride (82Rb) PET imaging. Dynamic image series were iteratively reconstructed with 5- to 10-second frame durations over the first 2 minutes for the blood phase and 10 to 80 seconds for the tissue phase. Motion shifts were assessed by 3 physician readers from the dynamic series and analyzed for frequency, magnitude, time, and direction of motion. The effects of this motion isolated in time, direction, and magnitude on global and regional MBF and MFR estimates were evaluated. Flow estimates derived from the motion corrected images were used as the error references.
RESULTS: Mild to moderate motion (5-15 mm) was most prominent in the blood phase in 63% and 44% of the stress and rest studies, respectively. This motion was observed with frequencies of 75% in the septal and inferior directions for stress and 44% in the septal direction for rest. Images with blood phase isolated motion had mean global MBF and MFR errors of 2%-5%. Isolating blood phase motion in the inferior direction resulted in mean MBF and MFR errors of 29%-44% in the RCA territory. Flow errors due to tissue phase isolated motion were within 1%.
CONCLUSIONS: Patient motion was most prevalent in the blood phase and MBF and MFR errors increased most substantially with motion in the inferior direction. Motion correction focused on these motions is needed to reduce MBF and MFR errors.

Entities:  

Keywords:  Coronary blood flow; Coronary flow reserve; Image artifacts; Myocardial perfusion imaging: PET; Pharmacologic stress

Mesh:

Substances:

Year:  2018        PMID: 29572594      PMCID: PMC6151305          DOI: 10.1007/s12350-018-1256-1

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  18 in total

1.  Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.

Authors:  Venkatesh L Murthy; Masanao Naya; Courtney R Foster; Jon Hainer; Mariya Gaber; Gilda Di Carli; Ron Blankstein; Sharmila Dorbala; Arkadiusz Sitek; Michael J Pencina; Marcelo F Di Carli
Journal:  Circulation       Date:  2011-10-17       Impact factor: 29.690

2.  Effects of patient movement on measurements of myocardial blood flow and viability in resting ¹⁵O-water PET studies.

Authors:  Kazuhiro Koshino; Hiroshi Watabe; Junichiro Enmi; Yoshiyuki Hirano; Tsutomu Zeniya; Shinji Hasegawa; Takuya Hayashi; Shigeru Miyagawa; Yoshiki Sawa; Jun Hatazawa; Hidehiro Iida
Journal:  J Nucl Cardiol       Date:  2012-06       Impact factor: 5.952

3.  MRI-based nonrigid motion correction in simultaneous PET/MRI.

Authors:  Se Young Chun; Timothy G Reese; Jinsong Ouyang; Bastien Guerin; Ciprian Catana; Xuping Zhu; Nathaniel M Alpert; Georges El Fakhri
Journal:  J Nucl Med       Date:  2012-06-28       Impact factor: 10.057

4.  Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.

Authors:  Maria C Ziadi; Robert A Dekemp; Kathryn A Williams; Ann Guo; Benjamin J W Chow; Jennifer M Renaud; Terrence D Ruddy; Niroshi Sarveswaran; Rebecca E Tee; Rob S B Beanlands
Journal:  J Am Coll Cardiol       Date:  2011-08-09       Impact factor: 24.094

5.  Preserved coronary flow reserve effectively excludes high-risk coronary artery disease on angiography.

Authors:  Masanao Naya; Venkatesh L Murthy; Viviany R Taqueti; Courtney R Foster; Josh Klein; Mariya Garber; Sharmila Dorbala; Jon Hainer; Ron Blankstein; Frederick Resnic; Marcelo F Di Carli
Journal:  J Nucl Med       Date:  2014-01-09       Impact factor: 10.057

6.  MR-based respiratory and cardiac motion correction for PET imaging.

Authors:  Thomas Küstner; Martin Schwartz; Petros Martirosian; Sergios Gatidis; Ferdinand Seith; Christopher Gilliam; Thierry Blu; Hadi Fayad; Dimitris Visvikis; F Schick; B Yang; H Schmidt; N F Schwenzer
Journal:  Med Image Anal       Date:  2017-08-03       Impact factor: 8.545

7.  Evaluation of respiratory and cardiac motion correction schemes in dual gated PET/CT cardiac imaging.

Authors:  F Lamare; A Le Maitre; M Dawood; K P Schäfers; P Fernandez; O E Rimoldi; D Visvikis
Journal:  Med Phys       Date:  2014-07       Impact factor: 4.071

8.  Event-by-Event Continuous Respiratory Motion Correction for Dynamic PET Imaging.

Authors:  Yunhan Yu; Chung Chan; Tianyu Ma; Yaqiang Liu; Jean-Dominique Gallezot; Mika Naganawa; Olivia J Kelada; Mary Germino; Albert J Sinusas; Richard E Carson; Chi Liu
Journal:  J Nucl Med       Date:  2016-02-23       Impact factor: 10.057

9.  Motion detection and correction for dynamic ( 15)O-water myocardial perfusion PET studies.

Authors:  Alexandru Naum; Marko S Laaksonen; Helena Tuunanen; Vesa Oikonen; Mika Teräs; Jukka Kemppainen; Mikko J Järvisalo; Pirjo Nuutila; Juhani Knuuti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-09-03       Impact factor: 9.236

10.  Does quantification of myocardial flow reserve using rubidium-82 positron emission tomography facilitate detection of multivessel coronary artery disease?

Authors:  Maria C Ziadi; Robert A Dekemp; Kathryn Williams; Ann Guo; Jennifer M Renaud; Benjamin J W Chow; Ran Klein; Terrence D Ruddy; May Aung; Linda Garrard; Rob S B Beanlands
Journal:  J Nucl Cardiol       Date:  2012-03-14       Impact factor: 5.952

View more
  15 in total

1.  Simplified quantification of PET myocardial blood flow: The need for technical standardization.

Authors:  Jonathan B Moody; Edward P Ficaro; Venkatesh L Murthy
Journal:  J Nucl Cardiol       Date:  2018-11-05       Impact factor: 5.952

2.  The utility of 82Rb PET for myocardial viability assessment: Comparison with perfusion-metabolism 82Rb-18F-FDG PET.

Authors:  Jonathan B Moody; Keri M Hiller; Benjamin C Lee; Alexis Poitrasson-Rivière; James R Corbett; Richard L Weinberg; Venkatesh L Murthy; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2019-02-26       Impact factor: 5.952

3.  Creeping towards broader clinical application of PET myocardial blood flow quantification.

Authors:  Paul C Cremer; Frank P DiFilippo; Manuel D Cerqueira
Journal:  J Nucl Cardiol       Date:  2019-02-21       Impact factor: 5.952

4.  No need for frame-wise attenuation correction in dynamic Rubidium-82 PET for myocardial blood flow quantification.

Authors:  J D van Dijk; P L Jager; J P Ottervanger; C H Slump; J A van Dalen
Journal:  J Nucl Cardiol       Date:  2019-02-21       Impact factor: 5.952

5.  Body motion detection and correction in cardiac PET: Phantom and human studies.

Authors:  Tao Sun; Yoann Petibon; Paul K Han; Chao Ma; Sally J W Kim; Nathaniel M Alpert; Georges El Fakhri; Jinsong Ouyang
Journal:  Med Phys       Date:  2019-10-08       Impact factor: 4.071

6.  Automated dynamic motion correction using normalized gradient fields for 82rubidium PET myocardial blood flow quantification.

Authors:  Benjamin C Lee; Jonathan B Moody; Alexis Poitrasson-Rivière; Amanda C Melvin; Richard L Weinberg; James R Corbett; Venkatesh L Murthy; Edward P Ficaro
Journal:  J Nucl Cardiol       Date:  2018-11-07       Impact factor: 5.952

7.  Test-retest repeatability and software reproducibility of myocardial flow measurements using rest/adenosine stress Rubidium-82 PET/CT with and without motion correction in healthy young volunteers.

Authors:  Christina Byrne; Andreas Kjaer; Naja Enevold Olsen; Julie Lyng Forman; Philip Hasbak
Journal:  J Nucl Cardiol       Date:  2020-05-10       Impact factor: 5.952

Review 8.  Quantitative clinical nuclear cardiology, part 2: Evolving/emerging applications.

Authors:  Piotr J Slomka; Jonathan B Moody; Robert J H Miller; Jennifer M Renaud; Edward P Ficaro; Ernest V Garcia
Journal:  J Nucl Cardiol       Date:  2020-10-16       Impact factor: 5.952

9.  Moving forward with motion reduction, detection and correction in cardiac PET.

Authors:  Ernest V Garcia; Jonathon A Nye
Journal:  J Nucl Cardiol       Date:  2021-03-21       Impact factor: 3.872

10.  Added value of myocardial blood flow using 18F-flurpiridaz PET to diagnose coronary artery disease: The flurpiridaz 301 trial.

Authors:  Venkatesh L Murthy; Edward P Ficaro; Jonathan B Moody; Alexis Poitrasson-Rivière; Tomoe Hagio; Christopher Buckley; Richard L Weinberg; James R Corbett
Journal:  J Nucl Cardiol       Date:  2020-01-30       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.